Skip to main content
# Title Department Research Year
271 A novel dual-targeted rosiglitazone-loaded nanoparticle for the prevention of diet-induced obesity via the browning of white adipose tissue Department of Pharmaceutics 2021
272 Betaxolol‐loaded Niosomes Integrated Within pH‐sensitive in situ Forming
Gel for Management of Glaucoma
Department of Pharmaceutics 2021
273 Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia 2021
274 Colorimetric and fluorometric nanoprobe for selective and sensitive recognition of hazardous colorant indigo carmine in beverages based on ion pairing with nitrogen doped carbon dots Department of Pharmaceutical Analytical Chemistry 2021
275 Novel 2-Indolinone Based derivatives Targeting Cell Cycle Checkpoint’s Proteins as Potential Anticancer Agents Department of Medicinal Chemistry 2021
276 Towards understanding of the interaction of certain carbapenems with protein via combined experimental and theoretical approach Department of Pharmaceutical Analytical Chemistry 2021
277 Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity Department of Pharmaceutical Organic Chemistry 2021
278 The protein tyrosine phosphatase SHP-1 (PTPN-6) but not CD45 (PTPR-C) is essential for the ligand-mediated regulation of CD22 in BCR-ligated B cells Department of Pharmaceutical Organic Chemistry 2021
279 Novel Urea Linked Ciprofloxacin-Chalcone Hybrids having Antiproliferative Topoisomerases I/II Inhibitory Activities and Caspases-Mediated Apoptosis Department of Pharmaceutical Organic Chemistry 2021
280 Silver Nanoparticle-Coated Ethyl Cellulose Inhibits Tumor Necrosis Factor-α of Breast Cancer Cells Department of Industrial Pharmacy 2021